Zobrazeno 1 - 4
of 4
pro vyhledávání: '"María Navarro-Palou"'
Publikováno v:
Cytotherapy. 16:1092-1097
Background aims The adipose stromal vascular fraction (SVF) is a heterogeneous population of mononuclear cells that includes approximately 1–10% mesenchymal stromal cells. These SVF cells can be freshly obtained from human lipo-aspirates and repres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac1d7689d657d0977e8717d6aea6ec3
https://doi.org/10.1016/j.jcyt.2014.02.007
https://doi.org/10.1016/j.jcyt.2014.02.007
Autor:
Jordi Martinez-Serra, Carmen Ballester, Carmen Vidal, Josep Miquel Bauça, Sara SanFelix, Joan Besalduch, Teresa Bex, Juan Carlos Amat, Simona Soverini, Carmen Santos, Toni F. Marcús, Andrés Novo, Antonio Gutierrez, María Navarro-Palou, Teresa Ros
Publikováno v:
Clinical Biochemistry. 45:345-351
Objectives Within the laboratory protocols, used for the study of BCR-ABL resistance mutations in chronic myeloid leukemia patients treated with Imatinib, direct sequencing remains the reference method. Since the incidence of patients with a mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21075cd18bf12e3b30dddababcc1fd07
https://doi.org/10.1016/j.clinbiochem.2011.12.026
https://doi.org/10.1016/j.clinbiochem.2011.12.026
Autor:
Carlos Saus, Antonio Gutierrez, Joan Besalduch, Joana M. Plazas, Rafael Ramos, Elena Maffiotte, Matias Diaz, Jordi Gines, Juan Carlos Amat, María Navarro-Palou, Jordi Martinez-Serra, Oliver Vögler, Regina Alemany, Teresa Ros, Teresa Bex, Javier Martín
Publikováno v:
European Journal of Pharmacology. 658:57-64
Trabectedin, a naturally occurring substance isolated from the Caribbean marine invertebrate Ecteinascidia turbinata, is the active compound of the antitumor drug Yondelis®. The mechanism of action of Trabectedin has been attributed to interactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621ae3275a8a3ad3038f6724b55231d4
https://doi.org/10.1016/j.ejphar.2011.02.035
https://doi.org/10.1016/j.ejphar.2011.02.035
Autor:
Joan Besalduch, Bernardo Lopez, Jordi Martinez-Serra, Saúl Muñoz-Capó, Laura Fueyo, Jordi Gines, Toni F. Marcús, Antonio Gutierrez, María Navarro-Palou, Angela G Suquia, Rafael Ramos, Francisco Rubio, Teresa Ros, Juan Carlos Amat
Publikováno v:
OncoTargets and therapy
The xCELLigence system is a new technological approach that allows the real-time cell analysis of adherent tumor cells. To date, xCELLigence has not been able to monitor the growth or cytotoxicity of nonadherent cells derived from hematological malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae09a3639367b083f6188dffd51f1730
https://www.dovepress.com/xcelligence-system-for-real-time-label-free-monitoring-of-growth-and-v-peer-reviewed-article-OTT
https://www.dovepress.com/xcelligence-system-for-real-time-label-free-monitoring-of-growth-and-v-peer-reviewed-article-OTT